The largest database of trusted experimental protocols

3 protocols using live dead discriminator

1

Comprehensive NK Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
dNK cells were gated on as live, CD9+CD56+ cells. pbNK cells were gated on as live CD56+CD3 cells. The following Abs were used: Live/Dead discriminator (Life Technologies), CD9 (SN4 or M-L13 from eBioscience or BD Biosciences, respectively), CD56 (HCD56 from BioLegend), and CD3 (SK7) from BD Biosciences. Fibroblasts and macrophages were identified using CD10 (HI10a from BioLegend) and CD14 Abs (MφP9 and HCD14 from BD Pharmingen and BioLegend), respectively. The following Abs were used to stain KIRs: UPR1 (KIR2DL5) from BioLegend and Carlos Vilches (33 (link)); 179315 (KIR2DS4), 143211 (KIR2DL1), and 181703 (KIR2DL4) from R&D Systems; FES172 (KIR2DS4) and EB6 (KIR2DL1/S1) from Beckman Coulter; CHL (KIR2DL2/3/S2) from BD Pharmingen; DX9 (KIR3DL1) from BioLegend; NKVFS1 (KIR2DL1/2/3/S1/2/4) from Abcam; 5.133 (KIR3DL2) from Marco Colonna (34 (link)); and FLAG Abs from Sigma-Aldrich. Intracellular staining was performed according to the manufacturers’ instructions with Abs against Ki647 (BD Pharmingen), CCL3 (R&D Systems), and GM-CSF (BD Biosciences).
+ Open protocol
+ Expand
2

Quantification of Blood Cell Surface Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
For baseline quantification of surface receptors, blood leukocytes were stained and analyzed using flow cytometry as previously described [16 (link)]. Whole blood samples were collected into K2EDTA vacutainers (BD Biosciences) during the same blood draw described above. Samples were centrifuged at 400x g for 10 min at 4°C, plasma was removed, and cells were resuspended to the original volume in ice cold PBS containing 2.5 mM EDTA. Cells were kept on ice and in the dark for the remaining steps. Cells were incubated with a live/dead discriminator (Life Technologies) and an Fc-blocking reagent (TruStain FcX, BioLegend) for 15 min before an antibody cocktail was added for an additional 15 min. The antibody cocktail consisted of antibodies against CD16 (clone 3G8, BioLegend), CD14 (clone 61D3, eBioscience), CXCR2 (clone 5E8-C7-F10, eBioscience), activated CD11b (clone CBRM1/5, eBioscience), CD63 (clone H5C6, eBioscience), and CD66b (clone G10F5, eBioscience). Live, singlet cells were analyzed using a LSR Fortessa flow cytometer (BD Biosciences) and gated based on forward scatter, side scatter, and surface marker expression (neutrophils are defined as CD16High FSCHigh SSCMid, monocytes as CD14High CD63High FSCMid SSCMid, and NK cells as CD16Mid FSCLow SSCLow).
+ Open protocol
+ Expand
3

Comprehensive NK Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
dNK were gated on as live, CD9+ CD56+ cells. pbNK were gated on as live CD56+ CD3- cells. The following antibodies were used: LIVE/DEAD discriminator (LifeTechnologies), CD9 (SN4 or M-L13 from eBioscience or Becton Dickinson, respectively), CD56 (HCD56 from Biolegend) and CD3 (SK7) from Becton Dickinson. Fibroblasts and macrophages were identified using CD10 (HI10a from Biolegend) and CD14 antibodies (MφP9 and HCD14 from BD Pharmingen and Biolegend), respectively. The following antibodies were used to stain KIR: UPR1 (KIR2DL5) from Biolegend and Carlos Vilches (33 (link)); 179315 (KIR2DS4), 143211 (KIR2DL1) and 181703 (KIR2DL4) from R&D Systems; FES172 (KIR2DS4) and EB6 (KIR2DL1/S1) from Beckman Coulter; CHL (KIR2DL2/3/S2) from BD Pharmingen, DX9 (KIR3DL1) from Biolegend; NKVFS1 (KIR2DL1/2/3/S1/2/4) from Abcam; 5.133 (KIR3DL2) from Marco Colonna (34 ); and FLAG antibodies (Sigma Aldrich). Intracellular staining was performed according to manufacturers’ instructions with antibodies against Ki647, (BD Pharmingen), CCL3 (R&D Systems) and GM-CSF (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!